Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early High Dose Chemotherapy and Autologous Stem Cell Transplant vs Conventional ABVD in Advanced Hodgkin's Disease
NCT00005090Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2000
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carmustine, etoposide, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by SWOG Cancer Research Network. Started Apr 2000; status: terminated.
02
Drugs
carmustineetoposidecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00005090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005090.